Net Cash Provided by (Used in) Operating Activities |
1.84M |
USD |
+32.3% |
Q3 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
9.48M |
USD |
|
Q3 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-13.2M |
USD |
-7.25% |
Q3 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q1 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.86M |
USD |
+84.5% |
Q3 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.67M |
USD |
-33.1% |
Q1 2023 |
Q3 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
282K |
USD |
-13.8% |
Q3 2022 |
Q1 2023 |
Payments to Acquire Property, Plant, and Equipment |
67K |
USD |
-23.9% |
Q3 2022 |
Q1 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-4.3M |
USD |
-14.2% |
Q1 2023 |
Q3 2023 |
Property, Plant and Equipment, Gross |
14.9M |
USD |
+0.97% |
Q2 2022 |
FY 2022 |
Deferred Income Tax Expense (Benefit) |
-117K |
USD |
-388% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
52K |
USD |
-7.14% |
Q2 2022 |
FY 2022 |
Depreciation, Depletion and Amortization |
264K |
USD |
-50.2% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
4.84M |
USD |
+305% |
Q2 2022 |
FY 2022 |
Interest Expense |
2.71M |
USD |
+51.8% |
Q1 2023 |
Q3 2023 |